Rocket Pharmaceuticals initiated at Leerink
Rocket Pharmaceuticals initiated with an Outperform at Leerink. Leerink analyst Mani Foroohar initiated Rocket Pharmaceuticals with an Outperform rating and a price target of $22.https://thefly.com/landingPageNews.php?id=2828751
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.